Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Previews LinkedIn (LNKD) Q4
-
Carbonite (CARB) May Catch the Eye of Small-Cap Value Investors
-
Notable Analyst Rating Changes 02/04: (BBRY) (BRO) (WU) Upgraded; (BUD) (WMT) (VOD) Downgraded
-
Canaccord Genuity Starts Deutsche Bank (DB) at Buy
-
Canaccord Genuity Starts Credit Suisse (CS) at Hold
-
Canaccord Genuity Upgrades Perrigo Co. (PRGO) to Buy
-
Streetinsider.com's Hot Lunchtime Reads 02/01: (VIAB) (NFLX) (ZMH) (INTC)
-
Canaccord Genuity Boosts PT Zimmer (ZMH) After Q4, Sees Strong 2013/2014
-
Ultratech (UTEK) Posts Best Qtr in Recent Memory, PT Raised - Canaccord Genuity
-
Canaccord Genuity Says Constant Contact (CTCT) Qtr 'Respectable' But Won't Cause a 'Short-Covering Panic'
-
Streetinsider.com's Hot Lunchtime Reads 01/31: (GM) (RIMM) (JDSU) (SWKS) (GLD)
-
RIM (RIMM) New Phone Just Closed the Big Gap, Reiterate 'Sell' - Canaccord
-
Canaccord Genuity Boosts Price Target on Skyworks Solutions (SWKS) to $31
-
Canaccord Genuity Boosts Price Target on Intersil (ISIL) to $10
-
Towerstream (TWER) Prices 10M Offering at $3/Share
-
Canaccord Genuity Trims PT on Anacor Pharmaceuticals (ANAC), Keeps Buy
-
Aspen Technology (AZPN) Shares Should Rise 15-20% This Year - Canaccord Genuity
-
NewLink (NLNK) Prices 4M Offering at $11.40/Share
-
Canaccord Genuity Raises PT on Integrated Device Technology (IDTI) to $9 Post Q3
-
Qualcomm (QCOM) Sales to Samsung Will Offset Apple (AAPL) Decline
-
Canaccord Genuity Starts Furiex Pharmaceuticals (FURX) at Buy, Sees 112% Upside
-
Canaccord Genuity Downgrades Canadian Pacific Railway Limited (CP) to Sell
-
Canaccord Genuity Cuts Apple (AAPL) PT to $650, Keeps 'Buy' Rating
-
Canaccord Genuity Downgrades MAP Pharmaceuticals (MAPP) to Hold
-
Canaccord Genuity Downgrades Tiffany & Co. (TIF) to Hold
-
Canaccord Genuity Boosts Texas Instruments (TXN) Price Target to $33
-
Canaccord Genuity Ups Intuitive Surgical (ISRG) PT to $590 on Solid Q4
-
Google (GOOG) PT Upped to $830 at Canaccord Genuity
-
Canaccord Genuity Boosts Cree (CREE) PT to $37
-
Canaccord Genuity Upgrades Verizon Communications (VZ) to Buy
-
These 3 Beaten-Up Apple (AAPL) Suppliers Will Do Just Fine - Analyst
-
Canaccord Genuity Lowers Numbers on Deckers Outdoor (DECK)
-
Canaccord Genuity Downgrades Canadian Natural Resources Limited (CNQ) to Hold
-
Canaccord Genuity Cuts PT on Columbia Sportswear (COLM) After Q4 Warning
-
Canaccord Genuity Boosts PT on Xilinx (XLNX) Post Q3, Keeps 'Hold'
-
AVEO Pharmaceuticals (AVEO) Prices Offering at $7.50/Sh
-
AVEO Pharmaceuticals (AVEO) Plans Stock Offering
-
Touch-Enabled Notebooks a Positive Atmel (ATML)
-
InterMune (ITMN) Announces $105M Convertible Senior Notes Offering
-
Streetinsider.com's Hot Lunchtime Reads 01/15: (CMCSA) (TER) (MBI) (DELL) (STJ)
-
Canaccord Genuity Positive on GenMark Diagnostics (GNMK)
-
Canaccord Genuity Downgrades Thompson Creek Metals (TC) to Hold
-
Canaccord Genuity Downgrades Unilever (UN) to Hold
-
Canaccord Genuity Downgrades Vale S.A. (VALE) to Hold
-
Canaccord Genuity Downgrades Bill Barrett (BBG) to Hold
-
Wall Street Continues to Speculate About iPhone 5c-heap (AAPL)
-
Aegerion Pharma (AEGR) Prices 2.7M Offering at $26.64/Share
-
Nokia (NOK) Q4 Results Impress But Windows 8 Doubts Remain
-
Notable Analyst Rating Changes 01/07: (AMZN) (WAG) (INTC) Upgraded; (YHOO) (LOW) (ASML) Downgraded
-
UPDATE: Canaccord Genuity Downgrades Lowe's (LOW) to Sell; Changes Lack Direction

